Form 4: Vericel CEO Colangelo's RSU Vesting & Tax Actions

Vericel Corp's President and CEO, Dominick Colangelo, reported the vesting of Restricted Stock Units, including a deferral into phantom stock and shares withheld for tax obligations.

Summary

• Dominick Colangelo, President and CEO of Vericel Corp (VCEL), reported transactions related to the vesting of Restricted Stock Units (RSUs).
• On February 24, 2026, 18,250 shares of common stock were acquired due to the vesting of RSUs granted on February 22, 2024.
• These 18,250 shares were immediately deferred into phantom stock units under the Vericel Corporation Deferred Compensation Plan, payable in common stock upon an elected Benefit Distribution Date.
• An additional 18,250 shares of common stock were acquired on February 24, 2026, from the vesting of RSUs granted on February 20, 2025.
• To satisfy tax withholding requirements related to RSU vesting, 8,824 shares were disposed of by the Issuer at a price of $38.09 per share.
• Following these transactions, Dominick Colangelo directly beneficially owns 312,446 shares of common stock.
• The reporting person also beneficially owns 54,750 derivative securities in the form of Restricted Stock Units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It's a routine compensation transaction, with the vesting of RSUs being a positive for the executive, partially offset by shares sold for tax purposes. The deferral into phantom stock indicates a continued long-term stake.

Positives

• The vesting of 36,500 Restricted Stock Units (RSUs) represents a significant component of executive compensation, indicating continued alignment of management interests with shareholder value.
• The deferral of 18,250 shares into phantom stock units under the Deferred Compensation Plan suggests a long-term commitment by the CEO to the company's equity.

Negatives

• A disposition of 8,824 shares of common stock occurred to cover tax withholding obligations, reducing the direct beneficial ownership of the CEO.

Future Outlook

Remaining Restricted Stock Units (RSUs) granted on February 22, 2024, are scheduled to vest on February 22, 2027, and February 22, 2028. Remaining RSUs granted on February 20, 2025, are scheduled to vest on February 20, 2027, February 20, 2028, and February 20, 2029.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and subsequent tax-related dispositions, are common occurrences in publicly traded companies. These events reflect standard executive compensation practices and do not typically signal a change in strategic direction or operational performance. The deferral into phantom stock units aligns with common executive retention strategies.

Stakeholder Impact

• Shareholders: The transactions reflect standard executive compensation practices and do not indicate any immediate operational or strategic shifts. The CEO's continued equity stake, including deferred units, aligns his interests with long-term shareholder value.
• Employees: These transactions are specific to executive compensation and do not directly impact the broader employee base, though they are part of the company's overall compensation philosophy.

Next Steps

• Future vesting of remaining Restricted Stock Units granted on February 22, 2024, scheduled for February 22, 2027, and February 22, 2028.
• Future vesting of remaining Restricted Stock Units granted on February 20, 2025, scheduled for February 20, 2027, February 20, 2028, and February 20, 2029.

Key Dates

Keywords

Vericel Corp, VCEL, Dominick Colangelo, Restricted Stock Units, RSU vesting, Insider transaction, Form 4, Deferred Compensation Plan, Phantom Stock, Executive compensation